Although consumer wearables were not initially designed for clinical research, this has been changing over the last few years to the point that some predictions say that by 2025 at least 70% of clinical trials will use these kinds of devices. Wearables can potentially improve the data collection and analysis in clinical research by constantly tracking clinical measures remotely, both new and traditional, which may be harder to measure by conventional means (e.g gait, sleep, etc).
How can we define and validate new digital endpoints collected by wearables? What are the regulatory requirements for consumer wearables to be used in clinical research? Are sponsors and CROs partnering with wearables manufacturers to jointly define and validate new clinical endpoints? Join this meeting to discuss this and more with other thought leaders.